Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top
Pfizer reports strong Q4 earnings with the FY23 guidance
Views 29K Contents 4

PFE Earnings

- Q4 Non-GAAP EPS of $1.14 beats by $0.10.
- Revenue of $24.3B (+1.9% Y/Y) misses by $100M.

2023 Guidance:
- Rev of $67.0 to $71.0 Billion vs. $74.23B consensus
- Adjusted Diluted EPS of $3.25 to $3.45 vs $4.38 consensus

Revenues from COVID-19 products expected to grow in 2024 after reaching a low point in 2023 due to significant government supply on hand to start the year.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
+0
Translate
Report
11K Views
Comment
Sign in to post a comment
    28Followers
    7Following
    102Visitors
    Follow